Health And Medicine
-
Study finds similar success rates with two devices for breathing tube placement
Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read MoreDec 15, 2021
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read MoreDec 10, 2021
-
McLean elected as 2021 National Academy of Inventors Fellow
John McLean, Stevenson Professor of Chemistry and director of the Center for Innovative Technologies, has been elected a 2021 fellow of the National Academy of Inventors. Read MoreDec 8, 2021
-
A potential new approach for the treatment of schizophrenia
Researchers discover how a protein may treat schizophrenia, including reversing working memory deficits, a hallmark of schizophrenia for which there is currently no treatment. Read MoreDec 8, 2021
-
Ask An Expert: What is multisystem inflammatory syndrome in children (MIS-C) and what are the symptoms?
Dr. Sophie Katz, assistant professor of pediatric infectious diseases and associate medical director of the Pediatric Antimicrobial Stewardship Program, describes the symptoms and treatment of multisystem inflammatory syndrome in children (MIS-C). Read MoreDec 6, 2021
-
Ask an Expert: What do we know about the omicron variant?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read MoreDec 3, 2021
-
Gene discoveries give new hope to people who stutter
New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. Read MoreDec 2, 2021
-
Calipari named Dean’s Faculty Fellow
Erin Calipari, assistant professor of pharmacology and a member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. Read MoreNov 30, 2021
-
Watch: Lab-to-Table Conversations: “The Science of Beer” featuring biochemistry faculty and beer science alumni
Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read MoreNov 30, 2021
-
Jon Kaas receives Society for Neuroscience’s highest honor for pathbreaking cerebral cortex research
Distinguished psychology professor Jon Kaas has received the Ralph W. Gerard Prize in Neuroscience, the highest recognition from the Society for Neuroscience, for his pathbreaking work in illuminating the structure and function of the cerebral cortex and plasticity in the developing and adult brain. Read MoreNov 23, 2021
-
Burkewitz awarded $100,000 to conduct longevity research at the cellular level
Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Read MoreNov 22, 2021
-
Five from VUMC among most highly cited researchers
Five Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read MoreNov 18, 2021
-
Vanderbilt Nursing School informaticist receives $80,000 from the CDC to investigate nation’s PPE supply
Kelly Aldrich to lead year-long project modeling trends of hospital PPE. Read MoreNov 16, 2021
-
Learn about the science of longevity with Vanderbilt experts in virtual event
The School of Medicine Basic Sciences’ monthly Lab-to-Table Conversation will bring together research experts on Tuesday, Nov. 30, for a virtual discussion about our current understanding of the biology of longevity. Read MoreNov 15, 2021
-
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Stephen Fesik’s discovery of a cancer-targeting molecule has been made freely accessible through opnMe for global researchers to advance research into cancer therapeutics. Read MoreNov 15, 2021
-
CRISPR screen identifies new anti-inflammatory drug target
A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics. Read MoreNov 11, 2021
-
New way to bEET insulin resistance
Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. Read MoreNov 11, 2021
-
The challenge of rejection
Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants. Read MoreNov 10, 2021
-
VUMC researchers a step closer to broad ebolavirus protection
A combination of two broadly acting monoclonal antibodies isolated by researchers at Vanderbilt University Medical Center protected non-human primates from ebolavirus disease, which causes severe and often-fatal hemorrhagic fever in humans. Read MoreNov 10, 2021
-
Zost honored for research on COVID-19, other life-threatening viral diseases
Vanderbilt's Seth Zost, PhD, has been awarded a major international prize for his research on COVID-19 and other life-threatening viral diseases. Read MoreNov 10, 2021